SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!
YYL
Lv1
40 积分
2023-07-27 加入
最近求助
最近应助
互助留言
Physiologically based pharmacokinetic modelling to predict the pharmacokinetics of metoprolol in different CYP2D6 genotypes
1天前
已完结
Trastuzumab Deruxtecan: A Review in Gastric or Gastro-Oesophageal Junction Adenocarcinoma
1个月前
已完结
Skin toxicity of enfortumab vedotin: Proposal of a specific management algorithm
1个月前
已完结
Antibody-drug conjugates come of age in oncology
1个月前
已完结
The Journey of Antibody-Drug Conjugates: Lessons Learned from 40 Years of Development
1个月前
已完结
Racial disparities in immune-related adverse events of immune checkpoint inhibitors and association with survival based on clinical and biochemical responses
1个月前
已关闭
Critical insights into the evolving drug-approval process in China
2个月前
已关闭
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
2个月前
已完结
Effects of immune-related adverse events (irAEs) and their treatment on antitumor immune responses
2个月前
已完结
Incidence and recurrence of atrial fibrillation among patients with obstructive hypertrophic cardiomyopathy treated with mavacamten: a single-center experience
2个月前
已完结
没有进行任何应助
点赞
1天前
感谢
1个月前
感谢
1个月前
感谢
1个月前
感谢
1个月前
已下载【积分已退回】
1个月前
已下载【积分已退回】
2个月前
点赞
2个月前
感谢
2个月前
感谢
2个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论